Mike Ouimette
CIK 1822619 · View on SEC EDGAR ↗
First SEC filing: Jan. 26, 2021 · Latest: Jan. 26, 2021
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 20, 2023 | PLRX | S 10b5-1 | 4,755 | $17.55 | $83,450 | 60,443 Direct | -7.29% | Disposed | -93.3% (price as of 2026-08-20) |
| July 17, 2023 | PLRX | S 10b5-1 | 12,778 | $18.01 | $230,132 | 65,198 Direct | -16.39% | Disposed | -93.5% (price as of 2026-08-20) |
| April 3, 2023 | PLRX | S 10b5-1 | 200 | $27.46 | $5,492 | 50,789 Direct | -0.39% | Disposed | -95.7% (price as of 2026-08-20) |
| April 3, 2023 | PLRX | S 10b5-1 | 2,677 | $26.74 | $71,583 | 50,989 Direct | -4.99% | Disposed | -95.6% (price as of 2026-08-20) |
| March 30, 2023 | PLRX | S 10b5-1 | 4,874 | $26.52 | $129,258 | 53,666 Direct | -8.33% | Disposed | -95.6% (price as of 2026-08-20) |
| Jan. 23, 2023 | PLRX | S 10b5-1 | 20,000 | $34.19 | $683,800 | 5,947 Direct | -77.08% | Disposed | -96.6% (price as of 2026-08-20) |
| Dec. 22, 2022 | PLRX | S 10b5-1 | 2,928 | $19.38 | $56,745 | 5,947 Direct | -32.99% | Disposed | -94.0% (price as of 2026-08-20) |
| Dec. 20, 2022 | PLRX | S | 4,719 | $19.10 | $90,133 | 8,875 Direct | -34.71% | Disposed | -93.9% (price as of 2026-08-20) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Jan. 25, 2023 | PLRX | Stock Option (right to buy) | Common Stock (55,000) | $34.65 | Jan. 24, 2033 | 55,000 | Acquired |
| Jan. 23, 2023 | PLRX | Stock Option (right to buy) | Common Stock (10,000) | $24.32 | Oct. 8, 2030 | 10,000 | Disposed |
| Jan. 23, 2023 | PLRX | Stock Option (right to buy) | Common Stock (10,000) | $11.86 | Jan. 25, 2032 | 10,000 | Disposed |
| Jan. 23, 2021 | PLRX | Stock Option (right to buy) | Common Stock (15,520) | $26.50 | Jan. 22, 2031 | 15,520 | Acquired |
| Oct. 9, 2020 | PLRX | Stock Option (right to buy) | Common Stock (108,240) | $24.32 | Oct. 8, 2030 | 108,240 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
PLRX
J.D.Chief Legal and Compliance Officer and Secretary| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2024 | $442,936 | — | — | — | $177,174 | — | $13,350 | $1,994,260 |
| 2023 | $425,900 | — | — | — | $170,360 | — | $9,768 | $3,316,978 |
| 2022 | $398,000 | — | — | — | $191,040 | — | $2,009 | $2,542,248 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.